Table 3.
Selected characteristics of subjects who developed bradycardia (HR < normal for age)
| Age (yrs) | Sex | AR day 0 (min) | AR day 3 (min) | Drug | DEAQ (ng/ml) |
|---|---|---|---|---|---|
| 9 |
Female |
105 |
60 |
A-A |
NA |
| 12 |
Male |
97 |
62 |
A-A |
180 |
| 12 |
Male |
81 |
58 |
A-A |
346 |
| 12 |
Male |
112 |
57 |
A-A |
375 |
| 12 |
Female |
109 |
57 |
A-A |
NA |
| 12 |
Male |
100 |
56 |
A-A |
NA |
| 14 | Female | 88 | 56 | A-A | 324 |
AR=apex rate; DEAQ=desethylamodiaquine; NA=Not available; A-A=artesunate-amodiaquine; DEAQ=desethylamodiaquine concentration.